B使:II

Amira Hegazy1, Manar Salaheldin Ali1, Nabil Ahmed Mubarak1

  • 1Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt.

概括

在R-CHOP化疗中添加甲福明显著改善了扩散性大B细胞淋巴瘤 (DLBCL) 患者的结局,增加了完全缓解率和存活率,同时减少了复发. 这种组合显示出可以容忍的安全性.